* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Surgical Therapy for Heart Failure
History of invasive and interventional cardiology wikipedia , lookup
Remote ischemic conditioning wikipedia , lookup
Echocardiography wikipedia , lookup
Cardiothoracic surgery wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Coronary artery disease wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Heart failure wikipedia , lookup
Jatene procedure wikipedia , lookup
Cardiac surgery wikipedia , lookup
Electrocardiography wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Myocardial infarction wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
In the name of GOD 1 Treatment of End Stage Heart Failure Surgical Treatments Cardiac Resynchronization Treatment(CRT) 2 Surgical Treatment of Heart Failure CABGs in ischemic cardiomyopathy Mitral valve repair in patients with dilated cardiomyopathy Surgical Ventricular reconstruction(Dor procedure) Passive Cardiac support Device Heart Transplantation 3 Dor procedure for Ischemic Cardiomyopathy Purse string stitch around a nonviable scarred aneurysm to minimize the excluded area. The residual defect is sometimes covered by a patch made from Dacron, 4 pericardium, or an autologous tissue flap Dor procedure for Ischemic Cardiomyopathy The operation shortens the long axis, but leaves the short axis length unchanged, producing an increase in ventricular diastolic sphericity while the systolic shape becomes more elliptical 5 Cardiomyoplasty Cardiomyoplasty, also referred to as "dynamic cardiomyoplasty," Surgical therapy for dilated cardiomyopathy in which the latissimus dorsi muscle is wrapped around the heart and paced during ventricular systole. 6 Cardiomyoplasty Carpentier peformed the first successful surgery on a humen in 1985 7 Considered Criteria for Surgical Repair Anteroseptal MI, with dilated left ventricle (end-diastolic volume index >100 mL/m2) Depressed LVEF Left ventricular regional dyskinesis or akinesis >30 percent of the ventricular perimeter, and Either symptoms of angina, heart failure, or arrhythmias 8 The following are considered to be relative contraindications Systolic pulmonary artery pressure >60 mmHg Severe right ventricular dysfunction Regional dyskinesis or akinesis without dilation of the ventricle 9 LV Reconstruction for Nonischemic Cardiomyopathy Cardiomyoplasty experience has led to other novel approaches to heart failure. Observations suggested that some patients benefited from the diastolic "girdling" effect of the muscle wrap This observation led to the development of the Acorn device and Myosplint 10 LV Reconstruction for Nonischemic Cardiomyopathy Acorn device knitted polyester sock that is drawn up and anchored over the ventricles in order to limit left ventricular dilation Preliminary data suggest that the device produces an improvement in heart failure symptoms, LVEF, left ventricular enddiastolic dimension, and quality of life 11 INTRODUCTION Heart transplantation remains the ultimate treatment for heart failure 12 HEART TRANSPLANTATION ACTUARIAL SURVIVAL (1982-2000) 100 Half-life =9.1 years Conditional Half-life = 11.6 years Survival (%) 80 60 N=52,195 40 20 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Years Post-Transplantation 13 Who Should Not Be Offered a Heart Transplant? Irreversible PHTN or pulmonary parenchymal disease Irreversible renal or hepatic dysfunction Severe peripheral or cerebrovascular disease IDDM with end-organ damage Coexisting cancer Non-compliance, addiction Elderly patients (aprox > 70yo) 14 Intraaortic Balloon Pump (IABP) Provides temporary circulatory assistance – ↓ Afterload – Augments aortic diastolic pressure Outcomes – Improved coronary blood flow – Improved perfusion of vital organs 15 Ventricular Assist Devices Ventricular Assist Devices (VADs) (VADs) • Indications for VAD therapy • Postcardiotomy cardiogenic shock • Bridge to recovery or cardiac transplantation Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. 16 Left ventricular assist device 17 Cardiac Resynchronization Therapy for Heart Failure Patient Selection and Clinical Outcomes 18 CRT-Cardiac Resynchronization Therapy HOW IT WORKS: Standard implanted pacemakers equipped with two wires (or "leads") conduct pacing signals to specific regions of heart (usually at positions A and C). Biventricular pacing devices have added a third lead (to position B) that is designed to conduct signals directly into the left ventricle. Combination of all three lead > synchronized pumping of ventricles, inc. efficiency of each beat and pumping more blood on the whole. 19 Ventricular Dysynchrony Abnormal ventricular conduction resulting in a mechanical delay – Wide QRS (IVCD); typically LBBB morphology – Poor systolic function – Impaired diastolic function ECG depicting interventricular conduction delay 20 Cardiac Resynchronization Therapy Goals Improve hemodynamics Improve Quality of Life 21 Cardiac Resynchronization Therapy Cardiac resynchronization, in association with an optimized AV delay, improves hemodynamic performance by forcing the left ventricle to complete contraction and begin relaxation earlier, allowing an increase in ventricular filling time. Coordinate activation of the ventricles and septum. ECG depicting IVCD ECG depicting cardiac resynchronization 22 Achieving Cardiac Resynchronization Mechanical Goal: Pace Right and Left Ventricles Transvenous Approach – Standard pacing leads in RA and RV – Specially designed left heart lead placed in a left ventricular cardiac vein via the coronary sinus Cardiac Resynchronization System MIRACLE Study Population Symptomatic patients with heart failure 18 years of age NYHA Functional Class III or IV QRS duration 130 msec LVEF 35% by echocardiography LVEDD 55 millimeters (echo measure) Stable HF medical regimen for 1-month – ACE-I or substitute, if tolerated – β-blocker - stable regimen for 3-months Abraham WT, et al. Journal of Cardiac Failure 2000; Vol 6 No. 4. 24 THANKS FOR YOUR ATTENTION 25